4.7 Article

Cdc42 is a key regulator of B cell differentiation and is required for antiviral humoral immunity

Journal

JOURNAL OF EXPERIMENTAL MEDICINE
Volume 212, Issue 1, Pages 53-72

Publisher

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20141143

Keywords

-

Funding

  1. Cancer Research UK
  2. German Research Foundation [Ke1737/1-1]
  3. Institute Pasteur-Fondazione Cenci Bolognetti
  4. EMBO
  5. Royal Society Wolfson Research Merit Award
  6. Cancer Research UK [15691] Funding Source: researchfish
  7. The Francis Crick Institute [10004, 10035] Funding Source: researchfish

Ask authors/readers for more resources

The small Rho GTPase Cdc42, known to interact with Wiskott-Aldrich syndrome (WAS) protein, is an important regulator of actin remodeling. Here, we show that genetic ablation of Cdc42 exclusively in the B cell lineage is sufficient to render mice unable to mount antibody responses. Indeed Cdc42-deficient mice are incapable of forming germinal centers or generating plasma B cells upon either viral infection or immunization. Such severe immune deficiency is caused by multiple and profound B cell abnormalities, including early blocks during B cell development; impaired antigen-driven BCR signaling and actin remodeling; defective antigen presentation and in vivo interaction with T cells; and a severe B cell-intrinsic block in plasma cell differentiation. Thus, our study presents a new perspective on Cdc42 as key regulator of B cell physiology.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available